Lv5
915 积分 2020-08-10 加入
给刘宇宁的粉丝一篇文献吧
Comparison of the efficacy of Janus kinase inhibitors and adalimumab in rheumatoid arthritis: a meta-analysis
4天前
已完结
Efficacy and Safety of Zimlovisertib, Ritlecitinib and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
4天前
已完结
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
12天前
已完结
Nomenclature of Cutaneous Vasculitis
12天前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
13天前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
13天前
已完结
Obinutuzumab in untreated primary membranous nephropathy: An observational case series
13天前
已完结
Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial
13天前
已完结
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance
13天前
已完结
Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab
13天前
已完结
皖公网安备34019202002308
